Additionally, its structural similarity to EGF enables it to bind and activate EGFR downstream signaling pathways, triggering epithelial-mesenchymal transition (EMT) and enhancing tumor cell metastatic potential (27, 28). The gene discussed is EGFR; the disease is neoplasm.